Research Solutions IncRecord 53% gross margin, $666K Q4 net income, $1.4M adjusted EBITDA, and no borrowings with improved EBITDA/cash flow expected.

Research Solutions expects a low single-digit year-over-year decline in transactions or DocDel sales in fiscal 2027, with President, CEO and Chairman Roy Olivier saying he expects continued headwinds in that segment but improved EBITDA and cash flows for the year. The company reported fourth-quarter total revenue of $12.1 million, with platform subscription revenue of $5.3 million and transaction revenue of approximately $6.8 million, while gross margin reached 53%, a 200 basis point improvement over the fourth quarter of 2025 and a new quarterly record. Net income for the quarter was $666,000, or $0.02 per diluted share, and adjusted EBITDA was $1.4 million. For full-year fiscal 2026, total revenue was approximately $48.3 million and net income was $2.8 million, or $0.08 per diluted share, with cash and cash equivalents of $12.6 million as of June 30, 2026, and no outstanding borrowings under the revolving line of credit. Management said it does not give guidance but expects strong corporate and academic B2B sales in fiscal 2027, improving renewals and upsells, and a flat B2C business, after recording about $800,000 in AI-related bookings in the fourth quarter and more than 16 million scholarly reads through Scite by AI agents.
Research Solutions IncRecord 53% gross margin, $666K Q4 net income, $1.4M adjusted EBITDA, and no borrowings with improved EBITDA/cash flow expected.